c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy.
Galan-Moya EM, Hernandez-Losa J, Aceves Luquero CI, de la Cruz-Morcillo MA, Ramírez-Castillejo C, Callejas-Valera JL, Arriaga A, Aranburo AF, Ramón y Cajal S, Silvio Gutkind J, Sánchez-Prieto R.
Galan-Moya EM, et al. Among authors: ramon y cajal s.
Int J Cancer. 2008 Jan 15;122(2):289-97. doi: 10.1002/ijc.23063.
Int J Cancer. 2008.
PMID: 17893873
Free article.